Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease: An Open Label, Randomized, Multicenter Study

NCT04148820 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT04148820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04148820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease: An Open Label, Randomized, Multicenter Study
Lead sponsor
University of Roma La Sapienza
Phase
Phase 4
Overall status
Unknown status
Start date
November 1, 2019
Completion date
October 31, 2021
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic heart disease